VIVUS, Inc. (VVUS) Posts Q2 Loss of 25c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Vivus (VVUS) PT, Qsymia Sales Ramp Assumptions Cut at BofA/Merrill Lynch
August 8, 2014 6:57 AM EDTBofA/Merrill Lynch analyst Steve Byrne reiterated an Underperform rating and lowered his price target on Vivus (NASDAQ: VVUS) to $4.00 (from $5.00) following Q14 Qsymia revenue of $11 million, in-line with their view.
Byrne notes while an improvement from the $9.1 million in Q1... More



